Pages that link to "Q45864265"
Jump to navigation
Jump to search
The following pages link to Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity (Q45864265):
Displaying 13 items.
- Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects (Q21284428) (← links)
- Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri (Q24648204) (← links)
- Baicalein, Ethyl Acetate, and Chloroform Extracts of Scutellaria baicalensis Inhibit the Neuraminidase Activity of Pandemic 2009 H1N1 and Seasonal Influenza A Viruses. (Q30352178) (← links)
- Oncolytic adenoviruses kill breast cancer initiating CD44 CD24-/low cells (Q33298585) (← links)
- Functional foods and their role in cancer prevention and health promotion: a comprehensive review (Q33622636) (← links)
- Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity (Q34043636) (← links)
- Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer (Q36710972) (← links)
- Inactivation of clathrin heavy chain inhibits synaptic recycling but allows bulk membrane uptake (Q36860399) (← links)
- Dietary apigenin potentiates the inhibitory effect of interferon-α on cancer cell viability through inhibition of 26S proteasome-mediated interferon receptor degradation (Q37054312) (← links)
- Plant flavone apigenin: An emerging anticancer agent (Q49333292) (← links)
- Spatial regulation of Dia and Myosin-II by RhoGEF2 controls initiation of E-cadherin endocytosis during epithelial morphogenesis. (Q52719283) (← links)
- [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study] (Q94587790) (← links)
- [Repurposing chlorpromazine to treat COVID-19: the reCoVery study] (Q95262055) (← links)